Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence
Article 2016 en
Authors
QW
Qin Wang
PW
Peter Würtz
KA
Kirsi Auro
Abstract
1 min read
Background: Hormonal contraception is commonly used worldwide, but its systemic effects across lipoprotein subclasses, fatty acids, circulating metabolites and cytokines remain poorly understood. Methods: A comprehensive molecular profile (75 metabolic measures and 37 cytokines) was measured for up to 5841 women (age range 24–49 years) from three population-based cohorts. Women using combined oral contraceptive pills (COCPs) or progestin-only contraceptives (POCs) were compared with those who did not use hormonal contraception. Metabolomics profiles were reassessed for 869 women after 6 years to uncover the metabolic effects of starting, stopping and persistently using hormonal contraception. Results: The comprehensive molecular profiling allowed multiple new findings on the metabolic associations with the use of COCPs. They were positively associated with lipoprotein subclasses, including all high-density lipoprotein (HDL) subclasses. The associations with fatty acids and amino acids were strong and variable in direction. COCP use was negatively associated with albumin and positively associated with creatinine and inflammatory markers, including glycoprotein acetyls and several growth factors and interleukins. Our findings also confirmed previous results e.g. for increased circulating triglycerides and HDL cholesterol. Starting COCPs caused similar metabolic changes to those observed cross-sectionally: the changes were maintained in consistent users and normalized in those who stopped using. In contrast, POCs were only weakly associated with metabolic and inflammatory markers. Results were consistent across all cohorts and for different COCP preparations and different types of POC delivery. Conclusions: Use of COCPs causes widespread metabolic and inflammatory effects. However, persistent use does not appear to accumulate the effects over time and the metabolic perturbations are reversed upon discontinuation. POCs have little effect on systemic metabolism and inflammation.
Qin Wang, Peter Würtz, Kirsi Auro, Ville‐Petteri Mäkinen, Antti J. Kangas, Pasi Soininen, Mika Tiainen, Tuulia Tynkkynen, Jari Jokelainen, Kristiina Santalahti, Marko Salmi, Stefan Blankenberg, Tanja Zeller, Jorma Viikari, Mika Kähönen, Terho Lehtimäki, Veikko Salomaa, Markus Perola, Sirpa Jalkanen, Paul M Ridker, Olli T. Raitakari, Johannes Kettunen, Debbie A. Lawlor, Mika Ala‐Korpela
Peter Würtz, Qin Wang, Pasi Soininen, Antti J. Kangas, Ghazaleh Fatemifar, Tuulia Tynkkynen, Mika Tiainen, Markus Perola, Therese Tillin, Alun D. Hughes, Pekka Mäntyselkä, Mika Kähönen, Terho Lehtimäki, Naveed Sattar, Aroon D. Hingorani, Juan-Pablo Casas, Veikko Salomaa, Mika Kivimäki, Paul M Ridker, George Davey Smith, Mauno Vanhala, Debbie A. Lawlor, Olli T. Raitakari, Nish Chaturvedi,
Peter Würtz, Sarah Cook, Qin Wang, Mika Tiainen, Tuulia Tynkkynen, Antti J. Kangas, Pasi Soininen, Jaana Laitinen, Jorma Viikari, Mika Kähönen, Terho Lehtimäki, Markus Perola, Stefan Blankenberg, Tanja Zeller, Satu Männistö, Veikko Salomaa, Paul M Ridker, Olli T. Raitakari, Mika Ala‐Korpela, David A. Leon
Peter Würtz, Sarah Cook, Qin Wang, Mika Tiainen, Tuulia Tynkkynen, Antti J. Kangas, Pasi Soininen, Jaana Laitinen, Jorma Viikari, Mika Kähönen, Terho Lehtimäki, Markus Perola, Stefan Blankenberg, Tanja Zeller, Satu Männistö, Veikko Salomaa, Paul M Ridker, Olli T. Raitakari, Mika Ala‐Korpela, David A. Leon
Peter Würtz, Sarah Cook, Qin Wang, Mika Tiainen, Tuulia Tynkkynen, Antti J. Kangas, Pasi Soininen, Jaana Laitinen, Jorma Viikari, Mika Kähönen, Terho Lehtimäki, Markus Perola, Stefan Blankenberg, Tanja Zeller, Satu Männistö, Veikko Salomaa, Paul M Ridker, Olli T. Raitakari, Mika Ala‐Korpela, David A. Leon
Discussion(0)
No comments yet. Be the first to comment.